Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Shares Outstanding (2021 - 2025)

Bioventus' Shares Outstanding history spans 5 years, with the latest figure at $67.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 325.03% year-over-year to $67.1 million; the TTM value through Dec 2025 reached $67.1 million, up 325.03%, while the annual FY2025 figure was $67.1 million, 325.03% up from the prior year.
  • Shares Outstanding reached $67.1 million in Q4 2025 per BVS's latest filing, roughly flat from $67.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $67.1 million in Q4 2025 to a low of $15.8 million in Q2 2021.
  • Average Shares Outstanding over 5 years is $48.2 million, with a median of $61.9 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: plummeted 75.05% in 2024, then skyrocketed 325.03% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $15.8 million in 2021, then skyrocketed by 293.13% to $62.1 million in 2022, then rose by 1.94% to $63.3 million in 2023, then tumbled by 75.05% to $15.8 million in 2024, then surged by 325.03% to $67.1 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Shares Outstanding are $67.1 million (Q4 2025), $67.0 million (Q3 2025), and $66.9 million (Q2 2025).